Innovative Diagnostics for Public Health

InBios International develops and manufactures highly sensitive and specific immunodiagnostics for infectious diseases.

Our purpose is to serve the global marketplace with accurate, superior quality products that are easy to use and cost effective. InBios’ products are backed by 20+ years of experience.

InBios’ Joins FDA Meeting to Discuss Diagnostics

As the new coronavirus threatens to reach pandemic level, InBios leaders joined other industry representatives in a meeting convened by the U.S. Food and Drug Administration to discuss how diagnostics are evaluated during and after emergencies.

InBios has had preliminary communications with the FDA with respect to regulatory guidance regarding the best pathway for quick diagnostic development for the coronavirus.

Zika   •   Chikungunya   •   Dengue   •   West Nile   •   Japanese Encephalitis   •   Scrub Typhus   •   Visceral Leishmaniasis   •   Cutaneous Leishmaniasis   •   Chagas   •   Filariasis   •   Strongyloides   •   Leptospirosis   •   Melioidosis   •   Norovirus